semaglutide or tirzepatide side effects Comparative safety and of and tirzepatide: Implications for clinical decision-making in obesity management Semaglutide vs Tirzepatide for Weight

Key Takeaways Retatrutide is an investigational triple hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously

Some people felt dizzy or faint, but not more than expected in a group of people being stuck with needles

And participants taking the semaglutide lost about 14% of their body weight, and they had significantly greater reductions in knee pain and improvements in physical function compared with the placebo group

doi: 10.1111/bcpt.12974 135 TeramotoSMiyamotoNYatomiKTanakaYOishiHAraiHet al

This can both negatively effect blood sugar control but can also lead to increased hunger and cravings